GMC-252-L-Lys Salt

GMC-252-L-Lys Salt · Genmedica Therapeutics S.L.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GMC-252-L-Lys Salt, covering 2017-10-12 to 2017-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Multiple Ascending Dose Study of GMC-252-L-Lys Salt in Healthy Subjects and Type 2 Diabetics [Phase 1]